Thermo Fisher, Structura Biotechnology unveil particle analysis software
August 3, 2022 -- Thermo Fisher Scientific and Structura Biotechnology are partnering together on a new, single particle analysis software. The software will be a version of Structura's CryoSparc Live and will integrate with Thermo Fisher's Smart EPU software and cryo-transmission electron microscope technology.Read
More
UCLA researchers receive $4M from NIH for ‘miniscope’ August 8, 2022 -- University of California, Los Angeles (UCLA) brain researchers have received a $4 million National Institutes of Health (NIH) grant to observe neuronal activity in freely moving animals with a “miniscope.”Read More
Gene therapy shows promise in treating ALS in rodent models
August 2, 2022 -- A gene therapy, patented through the University of California, San Diego and the Department of Veterans Affairs, and licensed to Eikonoklastes Therapeutics, measurably delayed disease onset in humanized mouse and rat models of familial amyotrophic lateral sclerosis (ALS).Read More
Researchers overcome NMR concentration limitation with powerful amplifier August 9, 2022 -- Researchers at the University of Vienna have come up with an unconventional way toward overcoming the traditional concentration limitation for determining the structure and dynamics of proteins using nuclear magnetic resonance (NMR) spectroscopy.Read More
AI, computer models of brain cells open door to experiments not possible in lab August 9, 2022 -- Cedars-Sinai Medical Center researchers used artificial intelligence (AI) to create what they contend are the most realistic and complex computer models of individual brain cells to date, enabling biological experiments not currently possible in the laboratory.Read More
Video from AACC: AACC president on Theranos, VALID Act August 1, 2022 -- Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago.Read More
New drug heals nervous system damage from stroke August 1, 2022 -- A new drug can repair nervous system damage caused by a stroke, at least in animal studies. In a preclinical study, researchers from the University of Cincinnati and Case Western Reserve University have found that one drug resulted in significant improvement in motor function, sensory function, spatial learning, and memory.Read More
Video from AACC: PerkinElmer on diagnostics, acquisitions August 2, 2022 -- Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.Read More
Genes
explain the effects of psychedelic drugs July 28, 2022 -- Not everyone has the same
response to psychedelic drugs and North Carolina researchers have figured out why -- seven genetic
variants of one serotonin receptor greatly impact a certain serotonin receptor’s structure and
function.Read More
Exhausted T cells can be resurrected August 8, 2022 -- Even the most exhausted T cells can be revived, according to University of Pittsburgh and University of Pittsburgh Medical Center researchers. Previously, it was thought when T cells reached a certain stage of exhaustion they were done, but a study published August 5 in Science Immunology shows that’s not the case.Read More
Seer debuts new proteomic-mapping software August 3, 2022 -- Seer has launched a new Proteogenomics Workflow that integrates deep proteomics with genomics and is powered by the Proteograph Analysis Suite 2.0.Read More
Video from AACC: Enzo BioChem CEO on COVID-19 test landscape August 1, 2022 -- Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics landscape as the COVID-19 pandemic evolves.Read More